TITLE

Recognition, Treatment and Complications of Meningococcal Disease

AUTHOR(S)
Andrew, F.; Riordan, I.; Thomson, A.P.J.
PUB. DATE
October 1999
SOURCE
Pediatric Drugs;Oct-Dec1999, Vol. 1 Issue 4, p263
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Meningococcal disease remains a major cause of death in young children. A decrease in mortality requires recognition and treatment of the disease at a number of stages in the illness. Life-threatening meningococcal disease usually presents as septicaemia rather than meningitis. The cardinal feature of meningococcal septicaemia is the purpuric rash. Many parents recognise the rash and seek medical advice because of it. When primary care physicians recognise the rash, the administration of parenteral penicillin may decrease mortality. However, antibacterials are not given promptly if there is no rash or if the disease presents in an atypical form. In hospital, antibacterial therapy with a third-generation cephalosporin should be given. Disease severity needs to be assessed by a valid method, such as the Glasgow Meningococcal Septicaemia Prognostic Score (GMSPS). This can identify those patients who need intensive care and/or might benefit from new therapies. The 2 life-threatening complications are septic shock and meningoencephalitis with raised intracranial pressure. Despite numerous case reports of success with potential new treatments, none has been proven safe and/or effective by controlled trials. Although it is tempting to focus on new treatments, the early recognition of severe meningococcal disease by parents, primary care physicians and junior hospital doctors is equally, if not more, important as a potential means of decreasing mortality.
ACCESSION #
6886244

 

Related Articles

  • Iatrogenic Fungal Meningitis. Macher, Abe M. // Annals of Internal Medicine;3/5/2013, Vol. 158 Issue 5, p364 

    A letter to the editor is presented in response to the article "Iatrogenic fungal meningitis: tragedy repeated," published in a previous issue of the periodical.

  • Fungal Meningitis a Factor? Dunbar, Mark T. // Review of Optometry;11/15/2012, Vol. 149 Issue 11, p77 

    A quiz concerning the treatment of an individual suffering from cryptococcus meningitis is presented.

  • Managing AIDS-related meningitis. Roccograndi, Julie F.; Clements, Kathleen Susan; Anderson, David // RN;Nov93, Vol. 56 Issue 11, p36 

    Provides tips regarding treatment of patients with AIDS-related cryptococcal meningitis. Symptoms of cryptococcal meningitis; Diagnostic workup; Nursing plan for comfort and safety; Reduction of side effects of antifungal drugs; Maintenance therapy for lifelong prophylaxis. INSET: How...

  • Guidelines for managing acute bacterial meningitis. Moller, Kirsten; Skinhoj, Peter // BMJ: British Medical Journal (International Edition);05/13/2000, Vol. 320 Issue 7245, p1290 

    Editorial. Provides information on the standardized guidelines for managing adult with acute bacterial meningitis in Great Britain. Prevention of secondary cases; Effectiveness of antibiotics in acute bacterial meningitis treatment; Prognosis of meningitis.

  • CNS infections--30 minutes to act. Anderson, David; Lipton, Jordan D. // Patient Care;5/30/1996, Vol. 30 Issue 10, p59 

    Presents a guide on the recognition and management of emergency cases involving patients with bacterial meningitis and central nervous system herpes infections. Clinical clues to bacterial etiologies; Definitive therapy; Vaccination. INSETS: The major meningeal pathogens today.;The rise of...

  • Streptococcus bovis Meningitis in an Otherwise Healthy Infant. Okumura, Akihisa; Takahashi, Hidaeki; Ogawa, Akimasa; Kuno, Kuniyoshi; Watanabe, Kazuyoshi // Clinical Pediatrics;Sep2002, Vol. 41 Issue 7, p523 

    Examines the effects of Streptococcus bovis on the health of the infants. Causes of meningitis; Analysis of the Cerebrospinal fluids; Treatment of the disease.

  • Cephalothin and cephaloridine therapy for bacterial meningitis. Fisher, Larry S.; Chow, Anthony W.; Yoshikawa, Thomas T.; Guze, Lucien B.; Fisher, L S; Chow, A W; Yoshikawa, T T; Guze, L B // Annals of Internal Medicine;May75, Vol. 82 Issue 5, p689 

    The efficacy of cephalothin and cephaloridine in the treatment of bacterial meningitis was evaluated from a review of 106 cases reported in the literature. Fifty-nine percent of 34 patients treated with intravenous cephalothin responded suboptimally; those receiving daily doses of 12 g or more...

  • "Too Numerous to Count" Lesions on Magnetic Resonance Images of the Brain. Mackowiak, Philip A. // Clinical Infectious Diseases;6/15/2003, Vol. 36 Issue 12, p1545 

    A previously healthy 49-year-old man presented with a 1-week history of fevers, chills, and frontal headache. The patient was born in the United States and denied recent travel, sick contacts, or exposure to animals. Empirical treatment for bacterial meningitis with multiple brain abscesses was...

  • Itraconazole therapy for chronic coccidioidal meningitis. Tucker, Richard M.; Denning, David W.; Dupont, Bertrand; Stevens, David A.; Tucker, R M; Denning, D W; Dupont, B; Stevens, D A // Annals of Internal Medicine;1/15/90, Vol. 112 Issue 2, p108 

    Study Objective: To assess the efficacy of orally administered itraconazole in the treatment of coccidioidal meningitis.Design: Prospective, nonrandomized open trial.Setting: Multicenter trial at an urban county hospital, a university referral center, and...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics